Kimryn Rathmell Archive — Page 3 of 3

Portrait of W. Kimryn Rathmell wearing glasses, a white blazer, and a navy floral blouse.
December 19, 2017

Rathmell elected to ASCO nominating committee

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO).

Three women stand at a table in a lecture hall; the center woman signs a poster while the others look on. Audience members sit in the background.
September 28, 2017

VU scientists discuss cancer treatments, cellular dynamics

A trio of Vanderbilt University scientists described their cutting-edge investigations of cellular dynamics and cancer treatment during last week’s Flexner Discovery Lecture.

August 17, 2017

Kidney cancer patient, survivor event set for Sept. 9

Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898.

Portrait of W. Kimryn Rathmell wearing glasses, a white blazer, and a navy floral blouse.
April 20, 2017

Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation.

Group of nine adults posing on a stage beside a podium, with palm plants and dark curtains in the background.
September 28, 2016

Celebration honors nine endowed chair recipients

Nine faculty members who hold endowed chairs were honored and donors were thanked during a festive celebration Sept. 26 at the Student Life Center.

Portrait of W. Kimryn Rathmell wearing glasses, a white blazer, and a navy floral blouse.
August 18, 2016

VICC helps launch new alliance for rare kidney cancer

Children, adolescents or young adults, particularly African-Americans, diagnosed with advanced kidney cancer may actually have a rare form of the disease known as renal medullary carcinoma (RMC) that requires a specialized approach and expert intervention.